Click here for Besponsa®▼ (inotuzumab ozogamicin) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Guide to help with your overall understanding of BESPONSA
evidence and guidelines
If you require more detailed information on BESPONSA, please go to Medical Information
Watch leading specialists discuss the data in the videos listed in the Explore More section below
Go to the Patient Support page to access support items for patients
Hear Professor David Marks discuss the INO-VATE study including MRD negativity, long term survival and reducing risks of veno-occlusive disease
Hear Dr. Anna Castleton discuss the key data for BESPONSA vs standard care from the INO-VATE study
For hard copies of Pharmacy Guide, Fast Facts and Patient Leaflets, please access Medisa
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. March 2021
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020